Central retinal artery occlusion: Difference between revisions
(Created page with "==Etiology== Retinal Embolism (20%) Atherosclerotic changes Angiospasm Inflammatory Endarteritis ==Epidemiology== Bilateral 1-2% M>F ==Symptoms== Painless, mono...") |
(Strip excess bold) |
||
| (58 intermediate revisions by 10 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | |||
*Acute interruption of blood flow to the retinal artery causing retinal ischemia | |||
*A stroke equivalent — 15-25% of patients will have an acute stroke or TIA within 1 week<ref name="lee">Lee J, et al. Risk of stroke in patients hospitalized with central retinal artery occlusion. ''Stroke''. 2013;44(4):967-971. PMID 23399955.</ref> | |||
*'''Ophthalmologic emergency''' — retinal tolerance for ischemia is approximately 90-100 minutes | |||
*Permanent vision loss occurs in most patients despite treatment | |||
*Average age: 60-65 years | |||
*Most common cause: thromboembolism from carotid artery atherosclerosis or cardiac source | |||
==Etiology== | ==Etiology== | ||
*Carotid artery atherosclerosis (most common) | |||
*Cardiac embolism (atrial fibrillation, valvular disease, endocarditis) | |||
*Giant cell arteritis (GCA) — '''must be excluded in patients >50''' | |||
*Hypercoagulable states | |||
*Vasculitis | |||
*Dissection of carotid or ophthalmic artery | |||
==Clinical Features== | |||
*Sudden, painless, monocular vision loss — often described as "lights went out" | |||
*Typically develops over seconds | |||
*Severe visual acuity loss (often counting fingers or light perception only) | |||
*Relative afferent pupillary defect (APD / Marcus Gunn pupil) | |||
*Fundoscopy: | |||
**Pale/white retina with cherry-red spot at fovea (pathognomonic) | |||
**Box-car segmentation of retinal vessels (intermittent blood flow) | |||
**Retinal edema | |||
*Branch RAO: visual field defect corresponding to affected branch | |||
==Differential Diagnosis== | |||
*[[Central retinal vein occlusion]] (hemorrhages on fundoscopy, less acute) | |||
*[[Retinal detachment]] | |||
*[[Optic neuritis]] (painful with eye movement) | |||
*[[Vitreous hemorrhage]] | |||
*[[Giant cell arteritis]] (GCA) with anterior ischemic optic neuropathy | |||
*[[Stroke (main)|Stroke]] affecting visual cortex | |||
== | |||
==Evaluation== | |||
*'''ESR and CRP''' — '''stat''' to evaluate for giant cell arteritis (ESR >50 in GCA) | |||
**If GCA suspected: start treatment immediately (see below) | |||
*Fundoscopic exam — cherry-red spot diagnostic | |||
*Intraocular pressure (IOP) — rule out [[Acute angle-closure glaucoma|acute glaucoma]] | |||
*CT/CTA head and neck — evaluate for stroke, carotid stenosis | |||
**May also obtain CTA to look for embolic source | |||
*ECG — evaluate for atrial fibrillation | |||
*Echocardiogram — evaluate for cardiac embolic source | |||
*Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c | |||
*MRI with DWI — assess for concurrent acute stroke | |||
==Management== | |||
*'''No proven treatment''' reliably restores vision; most interventions have limited evidence<ref name="mac">Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. ''Stroke''. 2021;52(6):e282-e294. PMID 33843236.</ref> | |||
*Traditional temporizing measures (limited evidence): | |||
**Ocular massage — intermittent digital pressure over closed eyelid (10-15 seconds on, 5 seconds off) | |||
**Attempt to dislodge embolus distally | |||
*Emergent ophthalmology consultation | |||
*If GCA suspected (age >50, elevated ESR, headache, jaw claudication): | |||
**Methylprednisolone 1 g IV daily x 3 days or Prednisone 1 mg/kg PO | |||
**Do NOT wait for temporal artery biopsy to start treatment | |||
*Stroke workup: same as [[TIA]] / [[Stroke (main)|stroke]] | |||
**Dual antiplatelet therapy, statin, carotid imaging | |||
*Consider emergent catheter-directed intra-arterial thrombolysis (tPA) at specialized centers if <6 hours (experimental) | |||
==Disposition== | |||
*Admit for stroke workup (telemetry, vascular imaging, echocardiography) | |||
*Emergent ophthalmology consultation | |||
*If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks | |||
*Treat as stroke equivalent with aggressive risk factor modification | |||
==See Also== | |||
*[[Central retinal vein occlusion]] | |||
*[[Retinal detachment]] | |||
*[[Stroke (main)]] | |||
*[[Giant cell arteritis]] | |||
*[[Acute angle-closure glaucoma]] | |||
==References== | |||
<references/> | |||
[[Category: | [[Category:Ophthalmology]] | ||
[[Category:Neurology]] | |||
Latest revision as of 09:26, 22 March 2026
Background
- Acute interruption of blood flow to the retinal artery causing retinal ischemia
- A stroke equivalent — 15-25% of patients will have an acute stroke or TIA within 1 week[1]
- Ophthalmologic emergency — retinal tolerance for ischemia is approximately 90-100 minutes
- Permanent vision loss occurs in most patients despite treatment
- Average age: 60-65 years
- Most common cause: thromboembolism from carotid artery atherosclerosis or cardiac source
Etiology
- Carotid artery atherosclerosis (most common)
- Cardiac embolism (atrial fibrillation, valvular disease, endocarditis)
- Giant cell arteritis (GCA) — must be excluded in patients >50
- Hypercoagulable states
- Vasculitis
- Dissection of carotid or ophthalmic artery
Clinical Features
- Sudden, painless, monocular vision loss — often described as "lights went out"
- Typically develops over seconds
- Severe visual acuity loss (often counting fingers or light perception only)
- Relative afferent pupillary defect (APD / Marcus Gunn pupil)
- Fundoscopy:
- Pale/white retina with cherry-red spot at fovea (pathognomonic)
- Box-car segmentation of retinal vessels (intermittent blood flow)
- Retinal edema
- Branch RAO: visual field defect corresponding to affected branch
Differential Diagnosis
- Central retinal vein occlusion (hemorrhages on fundoscopy, less acute)
- Retinal detachment
- Optic neuritis (painful with eye movement)
- Vitreous hemorrhage
- Giant cell arteritis (GCA) with anterior ischemic optic neuropathy
- Stroke affecting visual cortex
Evaluation
- ESR and CRP — stat to evaluate for giant cell arteritis (ESR >50 in GCA)
- If GCA suspected: start treatment immediately (see below)
- Fundoscopic exam — cherry-red spot diagnostic
- Intraocular pressure (IOP) — rule out acute glaucoma
- CT/CTA head and neck — evaluate for stroke, carotid stenosis
- May also obtain CTA to look for embolic source
- ECG — evaluate for atrial fibrillation
- Echocardiogram — evaluate for cardiac embolic source
- Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c
- MRI with DWI — assess for concurrent acute stroke
Management
- No proven treatment reliably restores vision; most interventions have limited evidence[2]
- Traditional temporizing measures (limited evidence):
- Ocular massage — intermittent digital pressure over closed eyelid (10-15 seconds on, 5 seconds off)
- Attempt to dislodge embolus distally
- Emergent ophthalmology consultation
- If GCA suspected (age >50, elevated ESR, headache, jaw claudication):
- Methylprednisolone 1 g IV daily x 3 days or Prednisone 1 mg/kg PO
- Do NOT wait for temporal artery biopsy to start treatment
- Stroke workup: same as TIA / stroke
- Dual antiplatelet therapy, statin, carotid imaging
- Consider emergent catheter-directed intra-arterial thrombolysis (tPA) at specialized centers if <6 hours (experimental)
Disposition
- Admit for stroke workup (telemetry, vascular imaging, echocardiography)
- Emergent ophthalmology consultation
- If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks
- Treat as stroke equivalent with aggressive risk factor modification
See Also
- Central retinal vein occlusion
- Retinal detachment
- Stroke (main)
- Giant cell arteritis
- Acute angle-closure glaucoma
References
- ↑ Lee J, et al. Risk of stroke in patients hospitalized with central retinal artery occlusion. Stroke. 2013;44(4):967-971. PMID 23399955.
- ↑ Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Stroke. 2021;52(6):e282-e294. PMID 33843236.
